Regulation of G2/M Transition by Inhibition of WEE1 and PKMYT1 Kinases
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regulation of G2/M Transition by Inhibition of WEE1 and PKMYT1 Kinases
Authors
Keywords
-
Journal
MOLECULES
Volume 22, Issue 12, Pages 2045
Publisher
MDPI AG
Online
2017-11-24
DOI
10.3390/molecules22122045
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structural Basis of Wee Kinases Functionality and Inactivation by Diverse Small Molecule Inhibitors
- (2017) Jin-Yi Zhu et al. JOURNAL OF MEDICINAL CHEMISTRY
- ATM, ATR, CHK1, CHK2 and WEE1 inhibitors in cancer and cancer stem cells
- (2017) Cyril Ronco et al. MedChemComm
- Identification of peptidic substrates for the human kinase Myt1 using peptide microarrays
- (2015) Alexander Rohe et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells
- (2015) Chad M. Toledo et al. Cell Reports
- Application of Docking and QM/MM-GBSA Rescoring to Screen for Novel Myt1 Kinase Inhibitors
- (2014) Kanin Wichapong et al. Journal of Chemical Information and Modeling
- Targeting the wee1 kinase for treatment of pediatric Down syndrome acute myeloid leukemia
- (2014) J. Timothy Caldwell et al. PEDIATRIC BLOOD & CANCER
- Pyrimidine-Based Tricyclic Molecules as Potent and Orally Efficacious Inhibitors of Wee1 Kinase
- (2014) Yunsong Tong et al. ACS Medicinal Chemistry Letters
- A Fluorescence Anisotropy–Based Myt1 Kinase Binding Assay
- (2013) Alexander Rohe et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Tumour selective targeting of cell cycle kinases for cancer treatment
- (2013) Marieke Aarts et al. CURRENT OPINION IN PHARMACOLOGY
- RNAi screening of the kinome with cytarabine in leukemias
- (2012) R. Tibes et al. BLOOD
- MEK1 inactivates Myt1 to regulate Golgi membrane fragmentation and mitotic entry in mammalian cells
- (2012) Julien Villeneuve et al. EMBO JOURNAL
- Evaluation of potential Myt1 kinase inhibitors by TR-FRET based binding assay
- (2012) Alexander Rohe et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The CDK1 inhibitory kinase MYT1 in DNA damage checkpoint recovery
- (2012) J P H Chow et al. ONCOGENE
- WEE1 Kinase Targeting Combined with DNA-Damaging Cancer Therapy Catalyzes Mitotic Catastrophe
- (2011) P. C. De Witt Hamer et al. CLINICAL CANCER RESEARCH
- Coupling of T161 and T14 phosphorylations protects cyclin B–CDK1 from premature activation
- (2011) Katia Coulonval et al. MOLECULAR BIOLOGY OF THE CELL
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- Checkpoint control and cancer
- (2011) R H Medema et al. ONCOGENE
- Switches and latches: a biochemical tug-of-war between the kinases and phosphatases that control mitosis
- (2011) M. R. Domingo-Sananes et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil
- (2010) Hiroshi Hirai et al. CANCER BIOLOGY & THERAPY
- Protein kinase signaling networks in cancer
- (2010) John Brognard et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Human kinome drug discovery and the emerging importance of atypical allosteric inhibitors
- (2010) Richard M Eglen et al. Expert Opinion on Drug Discovery
- Activation of cyclin B1–Cdk1 synchronizes events in the nucleus and the cytoplasm at mitosis
- (2010) Olivier Gavet et al. JOURNAL OF CELL BIOLOGY
- Positive-feedback loops in cell cycle progression
- (2009) Joseph R. Pomerening FEBS LETTERS
- The decision to enter mitosis: feedback and redundancy in the mitotic entry network
- (2009) Arne Lindqvist et al. JOURNAL OF CELL BIOLOGY
- Through the “Gatekeeper Door”: Exploiting the Active Kinase Conformation
- (2009) Fabio Zuccotto et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of gene expression-based pharmacodynamic biomarker for a p53 context-specific anti-tumor drug Wee1 inhibitor
- (2009) Shinji Mizuarai et al. Molecular Cancer
- Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents
- (2009) H. Hirai et al. MOLECULAR CANCER THERAPEUTICS
- Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms
- (2009) A Satyanarayana et al. ONCOGENE
- G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer
- (2008) N Bucher et al. BRITISH JOURNAL OF CANCER
- Uncovering mechanisms of bistability in biological systems
- (2008) Joseph R Pomerening CURRENT OPINION IN BIOTECHNOLOGY
- Myt1 protein kinase is essential for Golgi and ER assembly during mitotic exit
- (2008) Hiroyuki Nakajima et al. JOURNAL OF CELL BIOLOGY
- Rapid Cycling and Precocious Termination of G1 Phase in Cells Expressing CDK1AF
- (2008) Joseph R. Pomerening et al. MOLECULAR BIOLOGY OF THE CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started